文献速递炎症性肠病

肠道生态系统动态特性提示溃疡性结肠炎需联合治疗:靶向炎症与菌群

Dynamic Properties of the Intestinal Ecosystem Call for Combination Therapies, Targeting Inflammation and Microbiota, in Ulcerative Colitis.
PubMed 文献 · Gastroenterology · 2021-09-08

该研究分析儿童溃疡性结肠炎(UC)初治患者接受个体化抗炎治疗1年的数据,通过16S rRNA基因测序和粪钙卫蛋白评估菌群与宿主炎症状态。识别出4种菌群状态和4种宿主状态,纵向数据显示炎症改善伴随菌群改善,但两者均受替代状态屏障阻碍。结论提示抑制炎症应尽可能联合菌群管理以提高UC疗效。

要点

  • 儿童UC初治患者抗炎治疗1年,炎症与菌群状态同步改善但受替代状态屏障阻碍。
  • 识别出4种菌群状态和4种宿主状态,提示健康与疾病可能为替代稳定状态。
  • UC治疗或需在抗炎基础上联合菌群管理以突破状态屏障。

核心结论

  • 炎症抑制应尽可能联合菌群管理,以提高溃疡性结肠炎的治疗效果。

研究设计与样本

  • 基于儿童溃疡性结肠炎研究数据的分析,纳入初治新发患者,接受个体化抗炎治疗1年,于0、4、12、52周采集粪便,通过16S rRNA基因测序估计菌群状态、粪钙卫蛋白测量估计宿主炎症状态。

主要发现

  • 识别出4种菌群状态和4种宿主状态。
  • 纵向数据显示炎症状态改善伴随菌群状态改善,但两者改善均被替代状态屏障延缓或阻断。

临床怎么用

  • 在溃疡性结肠炎治疗中,除抗炎外应尽可能联合菌群管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Intestinal microbiota-host interactions play a major role in health and disease. This has been documented at the microbiota level ("dysbiosis" in chronic immune-mediated diseases) and through the study of specific bacteria-host interactions but rarely at the level of intestinal ecosystem dynamics. However, understanding the behavior of this ecosystem may be key to the successful treatment of disease. We recently postulated that health and disease represent alternative stable states of the intestinal ecosystem (different configurations that can exist under identical external conditions), which would require adapted strategies in disease treatment. Here, we examine if alternative stable states indeed exist in this ecosystem and if they could affect remission from ulcerative colitis (UC). METHODS: We analyzed data from a study on pediatric UC. The data reflect current treatment practice following the recruitment of treatment-naive patients with new-onset disease. Patients received personalized anti-inflammatory treatments over a period of 1 year. Stool samples at 0, 4, 12, and 52 weeks allowed an estimation of microbiota status (through 16S ribosomal RNA gene sequencing) and host inflammatory status (through the measurement of fecal calprotectin levels). RESULTS: We identify 4 microbiota states and 4 host states. Longitudinal data show that the improvement of inflammatory status is accompanied by an improvement of microbiota status. However, they also provide strong indications that both improvements are retarded or blocked by alternative states barriers. CONCLUSIONS: Our observations strongly suggest that inflammation suppression should be combined with microbiota management where possible to improve the efficacy of UC treatment.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. van de Guchte M, Mondot S, Doré J, et al. Dynamic Properties of the Intestinal Ecosystem Call for Combination Therapies, Targeting Inflammation and Microbiota, in Ulcerative Colitis. Gastroenterology. 2021. PMID: 34508776. doi:10.1053/j.gastro.2021.08.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。